Home/Filings/4/0001104659-26-002501
4//SEC Filing

Shemesh Shay 4

Accession 0001104659-26-002501

CIK 0001875558other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 4:32 PM ET

Size

5.0 KB

Accession

0001104659-26-002501

Insider Transaction Report

Form 4
Period: 2026-01-06
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
  • Award

    Common Stock

    2026-01-06+150,0001,793,068 total
Footnotes (2)
  • [F1]The 150,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Shemesh's continued service on such dates.
  • [F2]Includes shares of restricted common stock.

Issuer

Nuvectis Pharma, Inc.

CIK 0001875558

Entity typeother

Related Parties

1
  • filerCIK 0001896056

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:32 PM ET
Size
5.0 KB